Compare GXAI & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GXAI | SINT |
|---|---|---|
| Founded | 2021 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.3M | 11.1M |
| IPO Year | 2022 | 2007 |
| Metric | GXAI | SINT |
|---|---|---|
| Price | $1.18 | $1.88 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $11.00 |
| AVG Volume (30 Days) | ★ 3.3M | 46.2K |
| Earning Date | 05-14-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 71.35 | 59.45 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,933,030.00 | $1,018,000.00 |
| Revenue This Year | $271.23 | $30.26 |
| Revenue Next Year | $36.32 | $413.20 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 47901.74 | N/A |
| 52 Week Low | $1.02 | $1.85 |
| 52 Week High | $2.96 | $6.78 |
| Indicator | GXAI | SINT |
|---|---|---|
| Relative Strength Index (RSI) | 44.72 | 40.43 |
| Support Level | $1.06 | $1.93 |
| Resistance Level | $1.32 | $2.98 |
| Average True Range (ATR) | 0.07 | 0.15 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 29.06 | 27.59 |
Gaxos.AI Inc is a technology company focused on reshaping the way people interact with artificial intelligence across everyday life and high-impact industries. It is engaged in building a portfolio of AI-powered solutions designed to make advanced technology more practical, accessible, and transformative. The company's portfolio spans defense, health and wellness, entertainment, and productivity - bringing intelligent tools to markets where innovation can drive meaningful real-world outcomes. It operates as a single operating segment technology-based company that is developing applications aimed at redefining the way it utilizes artificial intelligence (AI) to optimize the user experience.
SINTX Technologies Inc is an advance ceramics company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. It provides biomedical solutions for medical devices specializing in silicon nitride (Si3N4) for musculoskeletal and antipathogenic applications. It also manufactures silicon nitride parts for customers in the electrical, aerospace, and other industrial sectors. The company is a globalised leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans. The Company operates as one operating segment.